How do we improve healthcare professionals’ understanding of #PEM, #MEcfs and #LongCOVID? Prof @sunsopeningband highlights the need for accessible, expert-led information, engagement with professional societies and stronger public health messaging.

Why can PEM symptoms be delayed? Prof @sunsopeningband explains #PEM can start hours or days after physical, cognitive, emotional or sensory exertion. Like waves building towards high tide, repeated exertion before symptoms settle can cause effects to accumulate. #LongCOVID

Long COVID care needs choice. @wanderingkayli shared recommendations for a hybrid model, prioritizing virtual care while keeping in-person appointments available when needed. Sustainable funding and policy are essential to make accessible care a reality. #LongCOVID #VirtualCare

How does #LongCOVID affect children at different ages? Dr Rachel Gross of NYU discusses the US RECOVER study, which is investigating Long COVID from infancy to young adulthood. Symptoms can vary by age, making research vital to better recognition and care.

Dr Funmi Okunola of Long COVID The Answers reflects on the final day of the 4th Canadian Symposium for Long COVID. #LongCOVID #longcovidtheanswers #DrFunmiOkunola

Can GP training in #LongCOVID continue? Dr Melvin Lafeber explains how Dutch Post-COVID centres help GPs recognise and manage Long COVID. But €27m in government funding ends in 2026, with no guaranteed extension. Patients need care while research continues.

Why is recognizing PEM so important in #LongCOVID? Post-exertional malaise (PEM) is more than ordinary #fatigue. As Professor @sunsopeningband Davenport explains, recognizing #PEM can help clinicians understand why exercise may worsen symptoms rather than improve them.

16,000 adults waiting for Post-COVID care in the Netherlands. Dr Melvin Lafeber says the DPACE post-COVID care & rehab network has seen 2,000 adults and hundreds of children, but faces a huge unmet need. The goal: expand care through regional hospitals &GPs. #LongCOVID

Why can exertion trigger a crash in #LongCOVID and #MEcfs? Prof @sunsopeningband explains how metabolic dysfunction, including problems converting fats and sugars into energy, may contribute to post-exertional malaise (PEM). Understanding why is key to better treatments.

POTS: What can help? Dr Jane McKay discusses fluids, salt, compression and medication. Heat can worsen symptoms, so compression needs may vary by season. Consult your healthcare provider before changing treatment. #LongCOVID #POTS #Dysautonomia

Day 2 of the Canadian Symposium for Long COVID! Dr Funmi Okunola checks in from UBC, looking ahead to a keynote by Professor Todd Davenport and updates on Long COVID research from across Canada. Follow for more highlights! #LongCOVID #LongCOVIDResearch #LongCOVIDPhysio

Children with #LongCOVID need more than symptom management. They need answers and treatments. At the Canadian Long COVID Symposium, Nandini shared her daughter’s five-year journey to answers and called for more research into pediatric Long COVID.

Could dysautonomia be going unrecognised in #LongCOVID? Dr Jane McKay highlights an important gap: people can experience significant orthostatic intolerance without meeting the strict heart-rate criteria for #POTS. youtu.be/6ZqWxewHNJ8

Day 1 at the Canadian Long COVID Symposium! Highlights, from research into Long COVID in children to POTS, healthcare barriers and emerging treatments. Progress is happening, but patients still need effective treatments & better access to care. More tomorrow! #LongCOVID

How can virtual care better support #LongCOVID patients? Kayli Jamieson launched a new guidebook based on a national survey of 621 people and patient focus groups. It offers recommendations to improve access to virtual care across Canada. #VirtualCare

Dr Alexandra Perel-Winkler, of the BC Centre for Long COVID, ME/CFS and Fibromyalgia, wants to turn scientific progress into practical support. Her hope? Actionable advice, better treatments and reasons for patients to feel hopeful. #LongCOVID #MEcfs #LongCOVIDResearch

Dr Funmi Okunola is at the 4th #Canadian Symposium for #LongCOVID, taking place at UBC. Over the coming days, she’ll be sharing highlights from the talks, new research &her own insights into developments in LC. Follow along for updates from Vancouver! #LongCOVIDResearch

Could microtesla magnetic therapy help people with #LongCOVID? At ISLC-PAIS, Blake Gurfein reported no adverse events in the first human trial of Fareon’s technology, involving 8 treatments over 1 month. Larger trials are needed to assess longer-term safety & potential benefits

Could blood vessel damage help explain the many symptoms of #LongCOVID? Profs @resiapretorius & Doug Kell discuss their research into abnormal clots, inflammation & vascular damage, how these changes may affect the microcirculation, oxygen delivery. #ISLCPAIS #LongCOVIDResearch

Why don’t all #LongCOVID studies tell the same story? Dr Odilia Corneth explains why different patient groups may show different biological patterns, and why disease duration matters. Understanding these differences could be key to more targeted treatments. #ISLCPAIS #MEcfs